🇺🇸 FDA
Patent

US 9550775

Substituted triazolopyridines and methods of use thereof

granted A61PA61P1/04A61P11/00

Quick answer

US patent 9550775 (Substituted triazolopyridines and methods of use thereof) held by Xenon Pharmaceuticals Inc. expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61P, A61P1/04, A61P11/00, A61P19/02, A61P21/02